Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α

Cell Transplantation

Volumn 20, Issue 10, 2011, Pages 1641-1647

  Matsumoto, Shinichi ^a   Takita, Morihito ^a   Chaussabel, Damien ^b   Noguchi, Hirofumi ^a   Shimoda, Masayuki ^c   Sugimoto, Koji ^a   Itoh, Takeshi ^a   Chujo, Daisuke ^b   Sorelle, Jeff ^d   Onaca, Nicholas ^e   Naziruddin, Bashoo ^e   Levy, Marlon F ^e  

^a Baylor All Saints Islet Cell Laboratory   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d BAYLOR UNIVERSITY   (United States)

^e BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

Interleukin 1 (IL 1 ); Islet transplantationl; Single donor; Thymoglobulin; Tumor necrosis factor (TNF )

Indexed keywords

ANTIINFLAMMATORY AGENT; DACLIZUMAB; ETANERCEPT; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; IODIXANOL; RAPAMYCIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; ORGAN PRESERVATION; PANCREAS DUCT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PURIFICATION; TRANSPLANTATION;

EID: 79957525661     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X564058     Document Type: Article

References (27)

1. Alejandro, R.; Barton, F. B.; Hering, B. J.; Wease, S. Col-laborative islet transplant registry investigators. 2008 Up-date from the collaborative islet transplant registry. Trans-plantation 86:1783-1788; 2008.
2. Allantaz, F.; Chaussabel, D.; Banchereau, J.; Pascual, V. Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr. Opin. Immunol. 19:623-632; 2007.
3. Balamurugan, A. N.; Breite, A. G.; Anazawa, T.; Logana-than, G.; Wilhelm, J. J.; Papas, K. K.; Dwulet, F. E.; McCarthy, R. C.; Hering, B. J. Successful human islet iso-lation and transplantation indicating the importance of class 1 collagenase and collagen degradation activity assay. Transplantation 89:954-961; 2010.
4. Balcazar, N.; Sathyamurthy, A.; Elghazi, L.; Gould, A.; Weiss, A.; Shiojima, I.; Walsh, K.; Bernal-Mizrachi, E. mTORC1 activation regulates beta-cell mass and prolifer-ation by modulation of cyclin D2 synthesis and stability. J. Biol. Chem. 284:7832-7842; 2009.
5. Bennet, W.; Groth, C. G.; Larsson, R.; Nilsson, B.; Kors-gren, O. Isolated human islets trigger an instant blood me-diated inflammatory reaction: Implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups. J. Med. Sci. 105:125-133; 2000.
6. Bennet, W.; Sundberg, B.; Groth, C. G.; Brendel, M. D.; Brandhorst, D.; Brandhorst, H.; Bretzel, R. G.; Elgue, G.; Larsson, R.; Nilsson, B.; Korsgren, O. Incompatibility be-tween human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907-1914; 1999.
7. Csorba, T. R.; Lyon, A. W.; Hollenberg, M. D. title typecontributorAutoim-munity and the pathogenesis of type 1 diabetes/title. title typejournalCrit. Rev. Clin. Lab. Sci. 47:51-71; 2010.
8. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S. H.; Zhang, H. J.; Parkey, J.; Hunter, D. W.; Sutherland, D. E. R. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830-835; 2005.
9. Kaizer, E. C.; Glaser, C. L.; Chaussabel, D.; Banchereau, J.; Pascual, V.; White, P. C. Gene expression in peripheral blood mononuclear cells from children with diabetes. J. Clin. Endocrinol. Metab. 92:3705-3711; 2007.
10. Long, E.; Wood, K. J. Regulatory T cells in transplanta-tion: Transferring mouse studies to the clinic. Transplanta-tion 88:1050-1056; 2009.
11. Markmann, J. F.; Kaufman, D. B.; Ricordi, C.; Schwab, P. M.; Stock, P. G. Financial issues constraining the use of pancreata recovered for islet transplantation: A white paper. Am. J. Transplant. 8:1588-1592; 2008.
12. Matsumoto, S. Islet cell transplantation for type 1 diabe-tes. J. Diabetes 2:16-22; 2010.
13. Matsumoto, S.; Noguchi, H.; Hatanaka, N.; Shimoda, M.; Kobayashi, N.; Jackson, A.; Onaca, N.; Naziruddin, B.; Levy, M. F. SUITO index for evaluation of efficacy of single donor islet transplantation. Cell Transplant. 18: 557-562; 2009.
14. Matsumoto, S.; Noguchi, H.; Shimoda, M.; Ikemoto, T.; Naziruddin, B.; Jackson, A.; Tamura, Y.; Olsen, G.; Fujita, Y.; Chujo, D.; Takita, M.; Kobayashi, N.; Onaca, N.; Levy, M. Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Trans-plant. 19:291-297; 2010.
15. Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Yamada, Y.; Fukuda, K.; Shibata, T.; Kasai, Y.; Maekawa, T.; Wada, H.; Naka-mura, T.; Tanaka, K. Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation 82:460-465; 2006.
16. Matsumoto, S.; Qualley, S. A.; Goel, S.; Hagman, D. K.; Sweet, I. R.; Poitout, V.; Strong, D. M.; Robertson, R. P.; Reems, J. A. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation method on human islet isolation, as assessed by the Edmonton isolation protocol. Transplanta-tion 74:1414-1419; 2002.
17. Matsumoto, S.; Rigley, T. H.; Qualley, S. A.; Kuroda, Y.; Reems, J. A.; Stevens, R. B. Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant. 11:769-777; 2002.
18. Matsumoto, S.; Yamada, Y.; Okitsu, T.; Iwanaga, Y.; Noguchi, H.; Nagata, H.; Yonekawa, Y.; Nakai, Y.; Ueda, M.; Ishii, A.; Yabunaka, E.; Tanaka, K. Simple evaluation of engraftment by secretory unit of islet transplant objects (SUITO) for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant. Proc. 37:3435-3437; 2005.
19. Mita, A.; Ricordi, C.; Messinger, S.; Miki, A.; Misawa, R.; Barker, S.; Molano, R. D.; Haertter, R.; Khan, A.; Miyagawa, S.; Pileggi, A.; Inverardi, L.; Alejandro, R.; Hering, B. J.; Ichii, H. Anti-proinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations. Cell Transplant. 19:1537-1546; 2010.
20. Noguchi, H.; Ikemoto, T.; Naziruddin, B.; Jackson, A.; Shimoda, M.; Fujita, Y.; Chujo, D.; Takita, M.; Kobay-ashi, N.; Onaca, N.; Levy, M. F.; Matsumoto, S. Iodixanol controlled-density gradient during islet purification im-proves recovery rate in human islet isolation. Transplanta-tion 87:1629-1635; 2009.
21. O'Gorman, D.; Kin, T.; Imes, S.; Pawlick, R.; Senior, P.; Shapiro, A. M. Comparison of human islet isolation out-comes using a new mammalian tissue enzyme versus col-lagenase NB-1. Transplantation 90:255-259; 2010.
22. Posselt, A. M.; Bellin, M. D.; Tavakol, M.; Szot, G. L.; Frassetto, L. A.; Masharani, U.; Kerlan, R. K.; Fong, L.; Vincenti, F. G.; Hering, B. J.; Bluestone, J. A.; Stock, P. G. Islet transplantation in type 1 diabetics using an im-munosuppressive protocol based on the anti-LFA-1 anti-body efalizumab. Am. J. Transplant. 10:1870-1880; 2010.
23. Ricordi, C.; Lacy, P. E.; Scharp, D. W. Automated islet isolation from human pancreas. Diabetes 38(Suppl. 1): 140-142; 1989.
24. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosup-pressive regimen. N. Engl. J. Med. 343:230-238; 2000.
25. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejan-dro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330; 2006.
26. Toso, C.; Edgar, R.; Pawlick, R.; Emamaullee, J.; Merani, S.; Dinyari, P.; Muller, T. F.; Shapiro, A. M.; Anderson, C. C. Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl. Int. 22:182-191; 2009.
27. Turgeon, N. A.; Avila, J. G.; Cano, J. A.; Hutchinson, J. J.; Badell, I. R.; Page, A. J.; Adams, A. B.; Sears, M. H.; Bowen, P. H.; Kirk, A. D.; Pearson, T. C.; Larsen, C. P. Experience with a novel efalizumab-based immuno-suppressive regimen to facilitate single donor islet cell transplantation. Am. J. Transplant. 10:2082-2091; 2010.